Powered by

ChromaCode Raises $12 Million in Series B for Commercial Launch and Appoints Alex Dickinson as Executive Chair

Apr 27, 2017 - PR Newswire
Board and Executive Moves-Investments

 ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Series B funding.  This latest round is led by New Enterprise Associates (NEA) with participation from existing investors Domain Associates, who led the Company's Series A round in 2015, and Okapi Ventures. 

The funding will be used to fuel development and establish the commercial infrastructure for ChromaCode's High-Definition Polymerase Chain Reaction technology (HDPCR(TM)). This software ...